Prototypic F-18-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma

Keller, Max and Maschauer, Simone and Brennauer, Albert and Tripal, Philipp and Koglin, Norman and Dittrich, Ralf and Bernhardt, Guenther and Kuwert, Torsten and Wester, Hans-Juergen and Buschauer, Armin and Prante, Olaf (2017) Prototypic F-18-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma. ACS MEDICINAL CHEMISTRY LETTERS, 8 (3). pp. 304-309. ISSN 1948-5875,

Full text not available from this repository. (Request a copy)

Abstract

The neuropeptide Y (NPY) Y-1, receptor (Y-1,R) selective radioligand (R)-N-a -(2,2-diphenylacety1)N-omega-[4(2[F-18]fluoropropanoylamino)butyllaminocarbonyl-N-(4-hydroxybenzy1)-argininamide ([F-18]23), derived from the high-affinity Y-1,R antagonist BIBP3226, was developed for imaging studies of Y-1,R-positive tumors. Starting from the argininamide core bearing amine-functionalized spacer moieties, a series of fluoropropanoylated and fluorobenzoylated derivatives was synthesized and studied for Y-1,R affinity. The fluoropropanoylated derivative 23 displayed high affinity (K-i = 1.3 nM) and selectivity toward Y1R Radiosynthesis was accomplished via F-18-fluoropropanoylation, yielding [F-18]23 with excellent stability in mice; however, the biodistribution study revealed pronounced hepatobiliary clearance with high accumulation in the gall bladder (>100 %ID/g). Despite the unfavorable biodistribution, [F-18]123 was successfully used for imaging of Y,R positive MCF-7 tumors in nude mice. Therefore, we suggest [F-18]23 as a lead for the design of PET ligands with optimized physicochemical properties resulting in more favorable biodistribution and higher Y-1,R-dependent enrichment in mammary carcinoma.

Item Type: Article
Uncontrolled Keywords: Y-1 RECEPTOR ANTAGONISTS; ACYLGUANIDINE BIOISOSTERIC APPROACH; POSITRON-EMISSION-TOMOGRAPHY; TARGETED TUMOR-DIAGNOSIS; BREAST-CANCER; PEPTIDE-HORMONES; HIGHLY POTENT; THERAPY; NEUROTENSIN; ANALOGS; Fluorine-18; antagonist; positron emission tomography; PET; neuropeptide Y; NPY; Y1R
Subjects: 500 Science > 540 Chemistry & allied sciences
Divisions: Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical/Medicinal Chemistry II (Prof. Buschauer)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 14 Dec 2018 13:00
Last Modified: 20 Feb 2019 10:41
URI: https://pred.uni-regensburg.de/id/eprint/263

Actions (login required)

View Item View Item